{"pub": "investing.com", "url": "https://in.investing.com/news/stock-market-news/briefindias-alkem-labs-st-louis-plant-gets-fda-form-483-with-4-observations-1980526", "downloaded_at": "2019-09-11 14:28:33.349380+00:00", "title": "BRIEF-India's Alkem Labs St. Louis Plant Gets FDA Form 483 With 4 Observations", "language": "en", "text": "BRIEF-India's Alkem Labs St. Louis Plant Gets FDA Form 483 With 4 Observations\n\nStock Markets 1 hour ago (Sep 11, 2019 18:51)\n\n\u00a9 Reuters. BRIEF-India's Alkem Labs St. Louis Plant Gets FDA Form 483 With 4 Observations Sept 11 (Reuters) - Alkem Laboratories Ltd : * INDIA'S ALKEM LABS SAYS US FDA HAS ISSUED AN ESTABLISHMENT INSPECTION REPORT FOR COMPANY'S MANUFACTURING FACILITY LOCATED AT ST. LOUIS * SAYS RECEIVED A FORM 483 ISSUED BY US FDA CONTAINING FOUR OBSERVATIONS * SAYS INSPECTION HAS NOW BEEN CLOSED BY US FDA\n\nBRIEF-India's Alkem Labs St. Louis Plant Gets FDA Form 483 With 4 Observations", "description": "BRIEF-India's Alkem Labs St. Louis Plant Gets FDA Form 483 With 4 Observations", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXMPEA6S0EV_L.jpg", "published_at": "2019-09-11"}